logo
  

ABIOMED Inc. (ABMD) Has Soared To A New High On Strong Q1 Earnings

ABIOMED Inc. (ABMD) reported first quarter GAAP EPS of $0.20 Tuesday morning, compared to the loss of $0.04 last year. The consensus estimate was for EPS of $0.08.

ABIOMED has gapped open sharply higher this morning and is now up 10.66 at $88.06 on above average volume. The stock has surged to a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT